These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 2439016
1. [Multimodality treatment of nasopharyngeal carcinoma]. Tanaka J, Inuyama Y, Fujii M, Takaoka T, Hosoda H, Kohno N. Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1789-96. PubMed ID: 2439016 [Abstract] [Full Text] [Related]
2. [Nasopharyngeal carcinoma]. Shimada F. Gan To Kagaku Ryoho; 1984 Jun; 11(6):1182-8. PubMed ID: 6203488 [Abstract] [Full Text] [Related]
3. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, Lu TX, Min HQ. J Clin Oncol; 2005 Feb 20; 23(6):1118-24. PubMed ID: 15657403 [Abstract] [Full Text] [Related]
6. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. Kwong DL, Sham JS, Au GK, Chua DT, Kwong PW, Cheng AC, Wu PM, Law MW, Kwok CC, Yau CC, Wan KY, Chan RT, Choy DD. J Clin Oncol; 2004 Jul 01; 22(13):2643-53. PubMed ID: 15226332 [Abstract] [Full Text] [Related]
7. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Azli N, Fandi A, Bachouchi M, Rahal M, Lianes P, Wibault P, Boussen H, Eschwege F, Armand JP, Cvitkovic E. Cancer J Sci Am; 1995 Jul 01; 1(3):222-9. PubMed ID: 9166480 [Abstract] [Full Text] [Related]
8. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases]. Khanfir A, Frikha M, Ghorbel A, Karray H, Drira MM, Daoud J. Cancer Radiother; 2006 Dec 01; 10(8):545-9. PubMed ID: 16807035 [Abstract] [Full Text] [Related]
9. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Chua DT, Nicholls JM, Sham JS, Au GK. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):11-20. PubMed ID: 15093894 [Abstract] [Full Text] [Related]
11. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, Lu TX, Au GK, Min HQ. Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1300-6. PubMed ID: 16750333 [Abstract] [Full Text] [Related]
14. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood. Nakamura RA, Novaes PE, Antoneli CB, Fogaroli RC, Pellizzon AC, Ferrigno R, Maia MA, Salvajoli JV, Pereira AJ, Nishimoto IN. Cancer; 2005 Aug 01; 104(3):525-31. PubMed ID: 15986481 [Abstract] [Full Text] [Related]
15. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma. Demizu Y, Sasaki R, Soejima T, Maruta T, Okamoto Y, Yamada K, Yoden E, Ejima Y, Ota Y, Ishida H, Nibu K, Sugimura K. Jpn J Clin Oncol; 2006 Oct 01; 36(10):620-5. PubMed ID: 16905756 [Abstract] [Full Text] [Related]
16. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS. Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654 [Abstract] [Full Text] [Related]
18. Prognostic factors and outcome for nasopharyngeal carcinoma. Farias TP, Dias FL, Lima RA, Kligerman J, de Sá GM, Barbosa MM, Gonçalves FB. Arch Otolaryngol Head Neck Surg; 2003 Jul 01; 129(7):794-9. PubMed ID: 12874084 [Abstract] [Full Text] [Related]